This online CME activity features the various presentations from the live meetings and includes discussions and patient cases of the following combinations of multiple comorbid chronic conditions:

• Atherosclerosis – Rheumatoid Arthritis
• COPD –  Osteoporosis
• Depression– OAB
• Hypogonadism – Type 2 Diabetes
• Atherosclerosis – Depression – Hypogonadism
• Diabetes – Osteoporosis - OAB
• RA – COPD/asthma 

Learning Objectives:

Atherosclerosis

• Outline optimal lipid targets based on patient-specific characteristics

• Design guideline-and-evidence-based treatment regimens for hyperlipidemia

• Identify strategies to engage patients in cardiovascular risk reduction

COPD/asthma

• Discuss similarities and differences between COPD and asthma, considering pathophysiology, epidemiology, Including smoking status, and symptomatology.

• Outline a step-by-step plan to evaluate and diagnose patients who are being assessed for asthma or COPD

Depression

• Describe the most current strategies for screening and diagnosing depression

• Describe appropriate and timely follow-up for patients with depression during the acute-treatment phase

• Initiate, monitor, and adjust appropriate therapeutic interventions for depression during the acute-and continuation-treatment phases

Diabetes

• Describe evidence and guideline-based recommendations for comprehensive care of patients with T2DM

• Integrate incretin-based therapy in the management of T2DM based on clinical evidence and current guideline recommendations

• Implement strategies to overcome common barriers to insulin initiation in T2DM

Hypogonadism

• Identify signs, symptoms, risk factors, and comorbid conditions that portend increased risk of hypogonadism, and clearly communicate the association with declining testosterone levels to patients
• Describe appropriate diagnostic procedures for suspected cases of hypogonadism
• Define potential risks and benefits of testosterone replacement therapy in hypogondadal men

Overactive bladder

• Identify the causes, signs, and manifestations of LUTS
• Describe diagnostic strategies for OAB that rule out other possible differential diagnoses
• Design evidence-based treatment strategies for patients with OAB that incorporate appropriate monitoring schedules

Osteoporosis

• Identify appropriate candidates for osteoporosis screening
• Describe validated fracture risk assessment techniques for patients with osteoporosis
• Design comprehensive treatment plans for patients with osteoporosis that incorporate pharmacologic and nonpharmacologic therapies

Rheumatoid arthritis

• Recognize signs and symptoms that are consistent with RA, and identify key elements in the differential diagnosis of join pain
• Identify appropriate diagnostic tests when RA is suspected, and provide timely referrals to rheumatologists when indicated
• Identify appropriate monitoring parameters and supportive and preventive care measures for patients receiving DMARD therapy